Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2024.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2023.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Pelvic Floor Disorders Among U.S. Military Active-Duty Females.

Urogynecology (Philadelphia, Pa.)·2024
Same author

Establishing a pharmacy revenue integrity team: A blueprint for increasing pharmacy's role in health-system revenue cycle.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2023
Same author

Dorsal Spanning Plate for Perilunate Dislocations.

Journal of wrist surgery·2022
Same author

Improper Restraint Use in Pediatric Patients Involved in Motor Vehicle Collisions.

The Journal of surgical research·2022

Related Experiment Video

Updated: May 12, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Apnea of prematurity: caffeine dose optimization.

Suzanne J Francart1, Megan K Allen, Jennifer Stegall-Zanation

  • 1Department of Pharmacy, The University of North Carolina Hospitals and Clinics, Chapel Hill, North Carolina.

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|April 26, 2013
PubMed
Summary

Higher maintenance doses of caffeine citrate (greater than 7.9 mg/kg/day) in premature neonates are safe and reduce the need for clinical interventions. This finding supports optimized caffeine therapy for apnea of prematurity.

Keywords:
apneacaffeine citratedosingneonatestachycardia

More Related Videos

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

Related Experiment Videos

Last Updated: May 12, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Pediatric Critical Care

Background:

  • Apnea of prematurity is common in neonates born before 28 weeks gestational age.
  • Caffeine citrate is a standard treatment for apnea of prematurity.
  • Optimal dosing strategies require further investigation.

Purpose of the Study:

  • To evaluate the correlation between caffeine citrate maintenance dose and response rates in preterm neonates.
  • To identify clinical indicators of response and adverse events like tachycardia.

Main Methods:

  • Retrospective analysis of 89 neonates (<28 weeks gestational age) treated with caffeine citrate.
  • Data collected on birth weight, gestational age, and caffeine dose.
  • Comparison of clinical interventions and tachycardia incidence based on dose.

Main Results:

  • Neonates receiving >7.9 mg/kg/day of caffeine citrate had fewer clinical interventions (76.3%) compared to those receiving ≤7.9 mg/kg/day (94.1%).
  • The incidence of tachycardia was low across all treatment groups.
  • Caffeine levels ranged from 16.6 to 34.4 μg/mL.

Conclusions:

  • Caffeine citrate doses exceeding 7.9 mg/kg/day are safe for neonates under 28 weeks gestational age.
  • Higher doses are associated with a reduced need for clinical interventions, suggesting improved efficacy.
  • Optimized caffeine dosing may enhance treatment outcomes for apnea of prematurity.